iBio develops and offers product applications of its iBioLaunch™ platform, which provides collaborators full support for turn-key implementation of the company’s technology for both proprietary and biosimilar products. IBIO’s iBioLaunch platform is a proprietary, transformative technology for the development and production of biologics using transient gene expression in unmodified green plants. The iBioModulator™ platform enables significantly improved vaccine products with higher potency and greater duration of effect. For more information visit the company’s Web site at www.ibioinc.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: